Effect of vincristine on glucose-induced insulin secretion in man.
60 min after the injection of therapeutic doses of vincristine for cancer chemotherapy, there is a reduction of the total (40%) and of the acute phase (43%) areas of insulin secretion inductedby 5-g i.v glucose load, and the constant of gllcose utilization is reduced by 25%. No differences are observed after 3 5-g i.v. glucose loads given at hourly intervals in control subjects.